The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS by Weller, Roy O. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
The meninges as barriers and facilitators for the movement of fluid, cells and
pathogens related to the rodent and human CNS









Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Weller, R. O., Sharp, M. M., Christodoulides, M., Carare, R. O., & Møllgård, K. (2018). The meninges as barriers
and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS. Acta
Neuropathologica, 135(3), 363-385. https://doi.org/10.1007/s00401-018-1809-z
Download date: 03. Feb. 2020
Vol.:(0123456789) 
Acta Neuropathologica (2018) 135:363–385 
https://doi.org/10.1007/s00401-018-1809-z
REVIEW
The meninges as barriers and facilitators for the movement of fluid, 
cells and pathogens related to the rodent and human CNS
Roy O. Weller1 · Matthew M. Sharp1 · Myron Christodoulides2 · Roxana O. Carare1 · Kjeld Møllgård3
Received: 5 November 2017 / Revised: 2 January 2018 / Accepted: 15 January 2018 / Published online: 24 January 2018 
© The Author(s) 2018. This article is an open access publication
Abstract
Meninges that surround the CNS consist of an outer fibrous sheet of dura mater (pachymeninx) that is also the inner peri-
osteum of the skull. Underlying the dura are the arachnoid and pia mater (leptomeninges) that form the boundaries of the 
subarachnoid space. In this review we (1) examine the development of leptomeninges and their role as barriers and facilita-
tors in the foetal CNS. There are two separate CSF systems during early foetal life, inner CSF in the ventricles and outer 
CSF in the subarachnoid space. As the foramina of Magendi and Luschka develop, one continuous CSF system evolves. 
Due to the lack of arachnoid granulations during foetal life, it is most likely that CSF is eliminated by lymphatic drainage 
pathways passing through the cribriform plate and nasal submucosa. (2) We then review the fine structure of the adult human 
and rodent leptomeninges to establish their roles as barriers and facilitators for the movement of fluid, cells and pathogens. 
Leptomeningeal cells line CSF spaces, including arachnoid granulations and lymphatic drainage pathways, and separate 
elements of extracellular matrix from the CSF. The leptomeningeal lining facilitates the traffic of inflammatory cells within 
CSF but also allows attachment of bacteria such as Neisseria meningitidis and of tumour cells as CSF metastases. Single 
layers of leptomeningeal cells extend into the brain closely associated with the walls of arteries so that there are no perivas-
cular spaces around arteries in the cerebral cortex. Perivascular spaces surrounding arteries in the white matter and basal 
ganglia relate to their two encompassing layers of leptomeninges. (3) Finally we examine the roles of ligands expressed by 
leptomeningeal cells for the attachment of inflammatory cells, bacteria and tumour cells as understanding these roles may 
aid the design of therapeutic strategies to manage developmental, autoimmune, infectious and neoplastic diseases relating 
to the CSF, the leptomeninges and the associated CNS.
Keywords Leptomeninges · CSF · Barriers and facilitators · Developing human and rat brain · Perivascular compartments 
and spaces · Attachment of Neisseria meningitidis, inflammatory cells and tumour cells to leptomeninges · Lymphatic 
drainage of the CNS
Introduction
The meninges covering the rodent and human CNS are 
divided primarily into the dura mater or pachymeninx and 
the arachnoid and pia mater or leptomeninges. Both dura 
and arachnoid encompass the brain and spinal cord and the 
arachnoid forms the outer barrier that contains CSF within 
the subarachnoid space (SAS). The pia is more closely 
applied to the brain and spinal cord but is separated from 
the CNS tissue on the surface of the CNS by a subpial space 
containing blood vessels and varying amounts of collagen.
For decades the meninges had been considered to be no 
more than a protective shield, but recent evidence suggests 
that leptomeninges have complex functions as barriers and 
facilitators for the movement of fluid, solutes and cells at 
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the surface of the CNS and of fluid and solutes within the 
CNS parenchyma. Thus, the SAS functions as an important 
distribution system. The fundamental pattern of blood sup-
ply to the CNS is different from that of most other organs in 
which a single artery and accompanying veins penetrate the 
surface at a single point and divide into smaller and smaller 
branches within the organ. In the CNS, the arteries branch 
and divide into small muscular arteries and arterioles within 
the SAS prior to entering the brain and spinal cord, the sur-
face of which is covered by a close network of numerous 
small vessels that enter and leave the CNS. The outer barri-
ers of the brain function as morphogenetic signalling centres 
[27, 89], dynamic transport systems [108], a stem cell niche 
[27] and regulators of immune cell entry into the CNS [93] 
as summarised by Brøchner et al. [14].
The adult CNS is separated from peripheral tissues by a 
set of structures and physiological mechanisms that are pre-
sent at various interfaces between the CNS parenchyma and 
surrounding fluids. Five main interfaces can be identified in 
the adult brain: (a) the arachnoid barrier, (b) the blood–brain 
barrier, (c) the blood–CSF barrier, (d) circumventricular 
organs (CVO) barrier formed by tight junctions between 
adjacent tanycytes, (e) the inner interface between the CSF 
and the brain (glia limitans) in the adult. An additional sixth 
interface, (f) the interface between the CSF and the embry-
onic brain is present only in the foetus [62, 83]. In the adult, 
an arachnoid blood–CSF barrier separates the fenestrated 
blood vessels in the dura from the CSF in the SAS by means 
of a cell layer joined by tight junctions (the arachnoid bar-
rier layer) [65]. Since the arachnoid blood–CSF barrier is 
avascular and provides a relatively small surface area, it is 
generally considered that it does not contribute significantly 
to blood–brain exchange [1]. However in light of recent find-
ings of drug transporters and drug-metabolising enzymes 
in the arachnoid blood–CSF barrier [108] and taking into 
account that the arachnoid barrier cell layer constitutes a 
much larger fraction of the brain surface area during early 
development, it is clear that the arachnoid blood–CSF bar-
rier is an important and changing interface that should not 
be ignored. It clearly warrants further investigation in the 
developing and adult brain.
In this review, we first examine the involvement of the 
leptomeninges in the development of the human and rat 
brains. We then review the structure of the adult leptome-
ninges to establish the interrelations between leptomenin-
ges, CSF, blood vessels and the CNS parenchyma. The 
human CNS is much larger than the rodent CNS and the 
anatomical arrangements between the leptomeninges, 
blood vessels and CNS parenchyma are much easier to dis-
cern in the human CNS than in rodents. We will therefore 
define the major structural attributes of the human lep-
tomeninges and compare them with rodent leptomeninges. 
This is an important aspect of the review as the majority of 
experimental studies examining the relationships between 
inflammatory cells and leptomeninges are performed in 
mice and how these studies relate directly to the human 
leptomeninges needs to be clearly defined. Although many 
investigations of the leptomeninges are performed through 
the medium of immunocytochemistry, ultrastructural stud-
ies form a valuable contribution to our understanding of 
the exact relationships between the delicate cell layers 
of leptomeninges and other structures within the human 
CNS. For this reason, we illustrate the structure of the 
adult human leptomeninges largely by their ultrastructure.
Barrier functions of the leptomeninges constitute an 
emerging field of research in both human and rodent CNS 
and are discussed in this review. However, just as impor-
tant to the biology and pathology of the CNS is the role 
of leptomeninges as facilitators for the movement of fluid, 
solutes and inflammatory cells in relation to the CNS and 
it diseases. Leptomeninges as facilitators for attachment 
and movement of cells are also important in infections 
and tumour metastases in the SAS. We will review the 
attachment of bacteria to leptomeningeal cells, especially 
with regard to Neisseria meningitidis, and the role that 
leptomeningeal elements may play in the location and 
spread of tumour metastases within the SAS. Although in 
its early stages, the identification of ligands on the surfaces 
of leptomeningeal cells to which bacteria and tumour cells 
attach has clear implications for therapies in these and 
other disorders involving the leptomeninges.
As often occurs in fields undergoing active investi-
gation, misconceptions have arisen and are perpetuated 
within the literature in relation to the leptomeninges and 
to the exchange and drainage of fluid associated with the 
CNS. For example, it has been assumed, perhaps wrongly, 
that the SAS is lined by collagen, that there are perivascu-
lar spaces for the entry of CSF into the brain and for the 
drainage of interstitial fluid (ISF) from the brain. Further-
more, the concept of the CSF as a sink for the drainage 
of ISF from the brain may need to be re-examined, par-
ticularly as the best estimate is that 85% of ISF from the 
brain drains to lymph nodes and only 15% of ISF passes 
into the CSF under normal conditions [94]. These experi-
ments were performed in the rat using radioiodinated 
serum albumin. Injections into the caudate nucleus and 
internal capsule resulted in 10–15% of tracer passing into 
CSF. Injections into the much smaller midbrain resulted 
in 60–75% efflux of tracer into the CSF which was prob-
ably due to direct efflux following injection into the very 
small midbrain. The probability of direct efflux of tracer 
into the CSF following injection into the brain through 
too large a needle in too great a volume was identified by 
Carare et al. [17].
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Meninges in the developing human and rat 
brains
Features of outer brain barrier and meningeal development 
in human and rat are summarised in Table 1 [14] (from 
Brøchner et al. [14]).
Human brain and meninges
In early foetal life, there are two separate CSF systems: inner 
CSF in the future cerebral ventricles and outer CSF in the 
future SAS. Following the development of the midline fora-
men of Magendi and the lateral foramina of Luschka, there 
is one continuous CSF system. However, during foetal life, 
CSF is not likely to drain through arachnoid granulations as 
they are not present prior to 39 weeks gestation [36]. They 
appear in greater number as children age and are clearly vis-
ible by 2 years and then increase further in size and number 
with increasing age [61]. Thus, it is likely that CSF at least 
in the neonatal brain is eliminated by lymphatic drainage 
pathways passing through the nasal submucosa [61].
By 5 weeks post-conception (wpc), the neural tube has 
closed around a fluid-filled neural cavity, initially filled with 
amniotic fluid but progressively modified and referred to 
as eCSF (embryonic cerebrospinal fluid) or the inner CSF. 
Closure of the neural tube occurs before the appearance of 
the choroid plexuses but also at a time when vascularisa-
tion of the brain tissue has barely begun. The first barriers 
or interfaces for exchange that develop in and around the 
embryonic brain are: (1) between the brain and inner CSF 
(eCSF) entrapped following closure of the neural tube; this 
occurs in humans 26 days post-conception (dpc) and (2) 
between the brain and loose vascular mesenchyme that is 
derived from the neural crest and forms the primary meninx 
at the outer surface of the brain anlage. There is no trace of a 
SAS at this time, just a primary meninx (meninx primitiva). 
Even when the SAS starts to develop, the origin of the fluid 
it contains is unclear. The fluid does not originate from the 
Table 1  Features of outer brain barrier and meningeal development (from Brøchner et al. [14])
The meninges and outer brain barriers form during embryogenesis and early foetal life. Many factors are involved in this dynamic process and 
are necessary for adequate development of the brain. O’Rahilly and Müller [70] described the development of the human meninges in 1986 
according to Carnegie stages, but have recently revised this staging model [71]. This Table is a summary of important events in the development 
of the human meninges and the barrier between the outer CSF and the brain approximated to weeks post-conception (wpc). Results in Carn-
egie stages have been translated according to the revision by O’Rahilly and Müller [71] and from mammals to human according to the work of 
Clancy et al. [22]
E14 etc. embryonic day 14, SAS subarachnoid space
Weeks post-conception Feature Species References
6th Appearance of a primary meninx around most parts of 
the brain
Human O’Rahilly and Müller [70]
Amoeboid microglial cells penetrate the brain by cross-
ing the pial basement membrane
Human Verney et al. [100]
7th The skeletogenous layer becomes visible Human O’Rahilly and Müller [70]
Differentiation of a leptomeningeal meshwork that is 
presumed to contain liquid and represent the future 
SAS
Human O’Rahilly and Müller [70]
8th The dural limiting layer is almost complete in hind-
brain and midbrain but only present in the area 
adjacent to the lateral fossa in the forebrain
Human O’Rahilly and Müller [70]
The fenestrated sinusoids of the pia–arachnoid become 
non-fenestrated (E14)
Rat (E14) Balslev et al. [10]
Most of the cisternae of the adult are already present Human O’Rahilly and Müller [70]
7th–10th Initial communication between the ventricular and 
subarachnoid compartments
Human and rat (E17) Brocklehurst [15], Johansson et al. [49]
11th Completion of the subpial end feet layer (E16) and 
claudin-11 positive arachnoid blood–CSF barrier 
(E18) and thereby appearance of a clearly defined 
SAS
Rat (E16 and E18) Balslev et al. [10]
12th–13th Second wave of microglial cells penetrate the brain via 
the BBB and inner CSF–brain barrier
Human Verney et al. [100]
12 (13th–15th) Radial glial cells begin to transform into astrocytes Rhesus monkey 
(E64) and newborn 
ferret
Schmechel and Rakic [86]; Voigt [101]
25th–28th Transition from subpial end feet layer to glia limitans Human Kadhim et al. [50]
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choroid plexus as this has not yet developed. Even when 
the choroid plexus has developed, CSF is secreted into a 
closed ventricular system that has no connection with the 
SAS. There are probably two separate CSF spaces until 10 
wpc in humans and E17 in the rat (Table 1). The outer CSF 
space is the future SAS and the inner CSF spaces are the 
future ventricles. At this stage of development, the forebrain 
is still devoid of vasculature [62].
Vascularisation
In the early stages of vascularisation of the brain, a loose 
vascular ectomesenchyme, derived from the neural crest, 
develops rostral to the mesencephalon and continues cau-
dally along the brain stem and spinal cord as a vascular 
mesenchyme originating from the paraxial mesoderm. This 
layer of loose mesenchymal tissue, that surrounds the neural 
tube and the developing early brain anlage, has been termed 
the primary meninx [70]. Prior to the development of the 
dura and the leptomeninges (arachnoid, SAS and pia) an 
extensive microvascular network of interdigitating small 
arterioles, capillaries and venules, termed the perineural 
vascular plexus (PNVP), is established by vasculogenesis 
at the surface of the neural tissue. Following differentiation 
of the leptomeninges from 7 to 10 wpc, the PNVP will form 
367Acta Neuropathologica (2018) 135:363–385 
1 3
a very dense leptomeningeal vascular plexus, the vascular 
distribution system, in the SAS [62].
Development of barriers in the brain
There is a clear distinction in the pattern of development 
between blood–brain and blood–CSF barriers and the com-
plex arachnoid barrier. In a recent paper, it was shown by 
claudin-11 immunolabelling that the interfaces associated 
with the human arachnoid barrier layer develop over a pro-
longed period of 5 weeks—from 7 wpc to 12 wpc—before 
there is a well delineated and, thus well-defined, subarach-
noid space [62]. The barrier layer appears first in the pos-
terior cranial fossa from where it extends rostrally towards 
the olfactory bulbs, initially covering the base of the skull 
from where it spreads towards the vertex (for a more detailed 
description, see [62]). This process, which is completed by 
the 12th wpc in humans corresponds to embryonic day 18 
(E18) in the rat (see Table 1) from which a number of new 
findings will be presented in the next section.
The interface between the outer CSF and the brain 
restricts diffusion between brain and subarachnoid CSF 
through an initial layer of radial glial end feet covered by 
a surface layer of pia and, in the third trimester, by glia 
limitans covered with a surface layer of pia [14]. Com-
plex barriers at the surface of the brain, particularly during 
development, are poorly defined [10], but by mid-gestation 
subarachnoid interfaces are almost fully developed. The SAS 
is delineated by the arachnoid barrier cell layer adjacent to 
the dura and the astrocyte end feet layer on the surface of the 
brain forming two individual interfaces: (1) the arachnoid 
forming a barrier or interface between the blood vessels in 
the dura and the outer CSF in the SAS and (2) the inter-
face between the outer CSF and the surface of the brain. In 
addition there is a third interface within the SAS between 
the outer CSF and the blood in the pial microvasculature 
[14]. The vasculature in the SAS is characterised from ear-
liest development by claudin-5 positive tight junctions in 
endothelial cells that confer its barrier properties as con-
firmed by the exclusion of plasma proteins, e.g. AFP [62].
Meninges and claudin‑11 in the developing rat brain
The tight junction protein, claudin-11, was initially 
described as the basis for the blood–testes barrier (Sertoli 
cell tight junctions) and shown to be the same as oligoden-
drocyte specific protein (OSP) responsible for the tight junc-
tions between oligodendrocytic myelin sheaths and axons 
[63]. Later, the developing arachnoid barrier cell layer was 
shown to be immunoreactive for claudin-11 in humans and 
in rats from E18 [14] and also in the E16 mouse [105]. The 
arachnoid is thus the barrier between the outer CSF in the 
SAS and the fenestrated blood vessels in the dura.
The general morphogenesis of cranial meninges in the rat 
was described by Angelov and Vasilev [6] at a time when 
claudin-11 as a marker for arachnoid barrier cells had not 
yet been identified. More recently it has been demonstrated 
that the early rat brain (E10–E14) shows no signs of clau-
din-11 immunoreactivity, but that at E15, weak staining is 
present in the loosely packed arachnoid barrier cells at the 
base of the brain and extending into the future tentorium 
cerebelli [14]. In the following description we summarise 
some new immunohistochemical findings from the stage in 
rat brain development (E18) in which a well-defined SAS 
is first present.
A large number of sagittal sections from the E18 rat were 
stained for claudin-11 to ensure that there is a complete arach-
noid barrier between the outer CSF and the fenestrated blood 
vessels in the dura, apart from the known openings where the 
cranial nerves perforate the dura-arachnoid (see Fig. 1A in 
Ref. [14]). Due to the interest in CSF flow, adjacent sections 
Fig. 1  Immunocytochemistry of the leptomeninges in the developing 
rat brain at low magnification. a–d Sagittal sections from an E18 rat 
brain at low magnification demonstrating the arachnoid barrier cell 
layer stained for claudin 11 (a, c), together with dural border cells 
and dura stained for AQP1 (d). b In contrast to the meninges that are 
immunonegative for AQP4, the astrocyte end feet layer of the entire 
ventral surface of the brain stem up to the cephalic flexure (CF) is 
strongly immunopositive for AQP4 (arrowheads). a Parasagittal sec-
tion at the level of the olfactory bulb (OB) depicting the discontinuity 
(‘the olfactory bulb hole’) (between arrows) in the arachnoid barrier 
cell layer indicated by arrowheads. b–d Consecutive near-midsagittal 
sections through the developing pineal gland (PG), third ventricle 
(3V) and median eminence (ME) and superior sagittal sinus (SSS) 
in d. Note the discontinuities in the barrier cell layer between dou-
ble arrows corresponding to the pineal gland (‘the peripineal slit’) 
and the median eminence (‘the peripituitary slit’) which is visible at 
higher magnification in e. The caudal part of the peripineal slit can 
be recognised even at low magnification between the central small 
and the larger arrow pointing to the pineal gland diverticulum. Higher 
magnifications of the cisterna magna (CM) and the subarachnoid 
space (SAS) in relation to the choroid plexus and brain surface are 
shown in Fig.  2. Note the dense group of oligodendrocyte progeni-
tor cells (OPC) facing the cephalic flexure in c. e, f At higher mag-
nification the meninges and their relationship to the pontine cistern 
(PC) and the primordium of the pituitary gland, including the pos-
terior lobe (PL), Rathke’s pouch (RP) and the anterior lobe (AL) are 
depicted. The ventral surface of the pons (P) and the basilar artery 
(BA) are not stained either for claudin-11 or AQP-1. The posterior 
lobe is separated from the cisterns of the subarachnoid space by a 
claudin-11-positive arachnoid barrier cell layer which terminates 
abruptly (small arrows) where the neurohypophysis emerges from 
the median eminence (ME). Note the strong AQP-1 immunoreactiv-
ity of the dural border cells (DBC) in f. 3V third ventricle, 4V fourth 
ventricle, AL anterior lobe, AQP-1 aquaporin-1, AQP-4 aquaporin-4, 
BA basilar artery, cld-11 claudin-11, CF cephalic flexure, CM cisterna 
magna, DBC dural border cells, LV lateral ventricle, ME median emi-
nence, OB olfactory bulb, OPC oligodendrocyte progenitor cells, P 
pons, PC pontine cistern, PG pineal gland diverticulum, PL posterior 
lobe, RP Rathke’s pouch, SAS subarachnoid space, SSS superior sagit-
tal sinus, TC tentorium cerebelli. a–d Same magnification. Scale bar 
2000 μm. e–f Same magnification. Scale bar 200 μm
◂
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were stained for aquaporin-1 and -4 (AQP-1 and AQP-4). Par-
asagittal sections at the level of the olfactory bulb demonstrate 
a consistently large disruption in the arachnoid barrier layer 
overlying the cribriform plate (‘the olfactory bulb hole’) pro-
viding free access for drainage of CSF to the nasal submucosa 
(Fig. 1a). Even in other midsagittal sections ‘the olfactory bulb 
hole’ is still present but now accompanied by discontinuities in 
the arachnoid barrier corresponding to the median eminence 
(the peripituitary slit’) and the pineal gland (‘the peripineal 
slit’) (Fig. 1c). Not only CSF but also blood cells belonging 
to the immune system could well pass into the SAS at this 
location.
Dura, including dural border cells, are immunoreactive for 
AQP-1 (Fig. 1d) but not for AQP-4 which stains the astrocyte 
end feet layer of the entire ventral surface of the brain stem 
(Fig. 1b). The arachnoid barrier cell layer covering the poste-
rior lobe of the pituitary is not positive for AQP-1 in contrast to 
the AQP-1 positive subdural border cells which are not stained 
for claudin-11 (compare Fig. 1e, f).
At higher magnification, strong claudin-11 immunoreactiv-
ity extends from the arachnoid barrier cell layer via arachnoid 
trabeculae towards the tela choroidea to cover the base of the 
stroma of the choroid plexus in both fourth and third ventricles 
(Fig. 2a, c). These findings are important in discussions about 
the continuity of the SAS and pial tissues with the stroma of 
the choroid plexus [107] and the so-called functional leak 
at the tela choroidea between ependyma and choroid plexus 
epithelium [13]. The claudin-11 positive pial cells within the 
stroma of the choroid plexus could well act as a narrow barrier 
layer between the blood and CSF in the SAS.
In addition to the AQP-1 immunoreactivity in dural bor-
der cells, choroid plexus epithelium and the external granular 
layer of the cerebellum, the leptomeningeal vascular plexus in 
the SAS covering the dorsal brain stem (Fig. 2b) and cortex 
(Fig. 2d) are clearly positively stained. These pial microves-
sels are also strongly immunoreactive for claudin-5 (Fig. 2e) 
in parallel with early human perineural and leptomeningeal 
blood vessels. Influx transporters—here exemplified by the 
excitatory amino acid transporter-1 (EAAT-1)—are also pre-
sent in the arachnoid barrier cell layer (arrowheads in Fig. 2f). 
Materials and methods are described in Brøchner et al. [14].
Meninges associated with the adult human 
brain
Dura mater
The cranial dura in humans is approximately 1 mm thick; 
it is composed of dense fibrous tissue and forms the inner 
periosteum of the skull. Sheets of dura, the falx cerebri and 
tentorium cerebelli divide the cranial cavity into three major 
compartments. In children, the dura adheres firmly to the 
sutures of the skull but, as the sutures close in young adults, 
the dura can be easily stripped from the inside of the skull; 
with advancing age, the dura adheres more firmly to the 
inner aspect of the skull. Much of the blood supply for the 
dura is derived from the middle meningeal branches of the 
maxillary artery and other arteries derived from the exter-
nal carotid and from branches of the occipital and vertebral 
arteries in the posterior fossa. Microscopically the dura con-
sists of densely packed bundles of collagen fibres with inter-
spersed arteries, veins and lymphatics. There is no barrier 
comparable to the blood–brain barrier associated with blood 
vessels in the dura. Major venous sinuses draining blood 
from the brain are enclosed within the cranial dura and dural 
lymphatics contribute to the drainage of CSF from the SAS 
[8, 54, 59]. As no direct connections between the brain and 
dural lymphatics have been established, it is unlikely that 
fluid and solutes from the brain drain into dural lymphatics.
Arachnoid separates easily from the inner aspect of the 
dura over most of the surface of the cerebral hemispheres 
in humans during surgical operations and at post-mortem. 
The only regions of adherence are where cortical veins join 
venous sinuses in the dura and where a small number of vas-
cular bundles containing arteries and veins cross the suba-
rachnoid and subdural spaces from the surface of the brain 
to the dura [11]. Such vascular bundles are mainly in the 
temporal regions and in the posterior fossa. Arteriovenous 
malformations in the dura have a significant effect on the 
vasculature of the brain through these connections and may 
be associated with cerebral venous thrombosis or intracra-
nial haemorrhage [82].
In the spinal column, the dura forms a tube around the 
outer layer of arachnoid and, in humans, is separated from 
the bones of the vertebral column by epidural adipose tissue 
and venous plexuses. There is a series of dentate ligaments 
along the length of the human spinal cord that connect the 
dura to the substantial layer of subpial collagen encompass-
ing the human spinal cord [68]; the dentate ligaments appear 
to stabilise the cord within the spinal SAS.
Both the cranial and spinal dura in rodents are much thin-
ner than in humans and are often best examined histologi-
cally within the intact skull [23]. As in humans, the rodent 
dura is composed of bundles of collagen fibres and also con-
tains arteries, veins and lymphatics [8, 54, 59].
Leptomeninges
General features of leptomeningeal cells
Leptomeningeal cells show variable ultrastructural and 
immunocytochemical characteristics depending upon the 
structures with which they are associated [4]. Intercellular 
junctions include tight junctions in the barrier layer of 
arachnoid where it abuts the dura and desmosomes in the 
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Fig. 2  Immunocytochemistry of the leptomeninges in the develop-
ing rat brain at higher magnification. a–f Higher magnification of c, 
d of Fig.  1a–d and two more consecutive sections stained for clau-
din-5 (e) and EAAT-1 (f). The claudin-11 immunoreactivity extends 
from the arachnoid barrier cell layer via some arachnoid trabecular 
cells (AT) towards the tela choroidea (TC) to cover the base of the 
stroma of the choroid plexus in the fourth and third ventricles (4V 
and 3V). The roof of the fourth ventricle, velum medullare (VM), is 
not reacting. Dural border cells (DBC), choroid plexus epithelium, 
external granular layer of the cerebellum (EGL) and the dense lep-
tomeningeal vascular plexus (LVP) covering the dorsal surface of the 
brain are stained for AQP-1. In e the dense leptomeningeal vascular 
plexus (LVP) in the subarachnoid space facing the dorsal brain sur-
face in a tangential section is strongly stained for claudin-5 (cld-5). f 
The immunoreactivity of the arachnoid barrier cell layer stained for 
influx transporter EAAT-1 (arrowheads). Note the similarity between 
the claudin-11 staining in c, e.g. next to the tela choroidea (TC), with 
that of the EAAT-1 staining but in contrast to the lack of AQP-1 reac-
tivity in d thus supporting the specificity of the immunoreactions. 3 V 
third ventricle, 4 V fourth ventricle; AQP-1 aquaporin-1, AQP-4 aqua-
porin-4, AT arachnoid trabecular cells; cld-5 claudin-5, cld-11 clau-
din-11, CM Cisterna magna, DBC dural border cells, EAAT -1 excita-
tory amino acid transporter-1, PG pineal gland diverticulum, PR 
pineal recess, SAS subarachnoid space, TC tela choroidea, VM velum 
medullare. a–f Same magnification. Scale bar 500 μm
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body of the arachnoid; desmosomes are also distributed to 
a lesser extent among leptomeningeal cells in the pia [4]. 
Most of the intercellular junctions between cells forming 
the pia, coating the trabeculae, arteries and veins in the 
SAS are relatively small gap junctions [13]. Immunocy-
tochemistry of leptomeningeal cells in the adult human 
brain has identified the presence of desmosomes and tight 
junctions and of vimentin and epithelial membrane antigen 
(EMA) in the cytoplasm of leptomeningeal cells.
Distribution of leptomeningeal cells in relation to the CNS
Leptomeningeal cells form substantial sheets such as the 
human arachnoid and thin, delicate sheets that form the pia 
on the surface of the CNS and coat trabeculae in the SAS. 
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Thin sheets of leptomeningeal cells extend into the CNS 
parenchyma around penetrating arteries. Leptomeningeal 
cells also surround collagen bundles in the stroma of the 
choroid plexus [3] and in the cores of arachnoid granulations 
[56, 98]. In this section, the structural features and func-
tional roles of the human leptomeninges will be reviewed 
and related to leptomeninges in rodents.
Arachnoid mater
The arachnoid forms a translucent sheet that encompasses 
the outer aspects of the cerebral and spinal SAS. In humans, 
the arachnoid is some 200 μm thick (Fig. 3a) and the main 
body of the arachnoid is composed of closely packed lep-
tomeningeal cells joined by desmosomes and devoid of base-
ment membranes [4]. In the outer barrier layer of the arach-
noid that abuts on to the dura, the cells are joined by tight 
junctions that relate to the function of the normal arachnoid 
as a barrier to the passage of CSF out of the SAS and the 
entry of solutes and cells into the SAS [4, 65]. Sheet-like 
and filiform trabeculae with cores of collagen fibres coated 
by leptomeningeal cells extend across the human SAS to 
join the pia on the surface of the brain (Fig. 3a). Trabeculae 
divide the SAS into compartments and also suspend arteries 
and veins within the SAS [4, 45].
Human spinal leptomeninges form an outer barrier layer 
of arachnoid that is closely applied to the inner aspects of 
the dura [68]. Intermediate layers of arachnoid within the 
spinal SAS are composed of a complex array of perforated 
sheets, mainly over the dorsal aspects of the spinal cord [68, 
103]; these perforated sheets may play a role in regulating 
the flow of CSF within the spinal SAS. Similar perforated 
sheets of leptomeninges form the delicate dorsolateral liga-
ments extending from the surface of the spinal cord to the 
arachnoid (Fig. 3b) [68, 103].
The SAS is shallower and much less extensive in rodents 
than in humans [23, 54]. Injection of tracers into the cisterna 
magna in rats shows that the SAS is most extensive over 
the base of the rodent brain and extends over the superior-
lateral aspects of the cerebral hemispheres mainly as narrow 
channels adjacent to major branches of the middle cerebral 
arteries [54]. SAS surrounds the whole circumference of the 
rodent spinal cord.
Pia mater
In both rodents and humans, the pia is composed of a thin 
layer of leptomeningeal cells that are joined by gap junctions 
[13] and occasional desmosomes. For the most part, the pia 
is only one cell layer thick and is reflected on to arteries and 
veins as they enter or leave the surface of the CNS (Fig. 3c). 
By this anatomical arrangement, the subpial spaces and the 
surface of the CNS are separated from the SAS by a thin 
layer of pia mater [4, 45, 68]. Arteries enter the surface of 
the human brain in two ways as shown in Fig. 3c [45]. They 
may pass obliquely from the SAS to run parallel to the sur-
face of the cortex as pial arteries in the subpial space (see 
white arrow in Fig. 3c). Alternatively, arteries enter perpen-
dicular to the surface of the brain where they are associated 
with a V-shaped depression in the pia as shown by the black 
arrow in Fig. 3c. Pial arteries running parallel to the surface 
of the cerebral cortex are surrounded by a single layer of 
pia (Fig. 4a) and are separated from the glia limitans on the 
surface of the cortex by subpial space. Veins in the subpial 
space may or may not be surrounded by pia [4, 109]; the vein 
in Fig. 4b has no sheath of pia. Pial cells can be identified 
on the surface of vessels by the presence of intercellular gap 
junctions (Fig. 4a, c); desmosomes that are so prominent 
in the arachnoid are less frequently seen in the pia. Base-
ment membranes associated with the cells of the pia may be 
incomplete (Fig. 4c, d). Within the subpial space delicate 
bundles of collagen fibres are interspersed with occasional 
inflammatory cells (Fig. 4a).
The pia and the subpial space are similar in structure in 
rodents and humans (Fig. 4a, b, d) but are more delicate in 
rodents; the basement membrane associated with the pia is 
variable in its extent.
Fig. 3  Leptomeninges in the adult human brain and spinal cord. 
a Subarachnoid space over the human cerebral hemispheres. The 
arachnoid encompasses the subarachnoid space (SAS) and trabecu-
lae, composed of collagen coated by leptomeningeal cells, extend 
across the SAS to join the pia covering the cerebral cortex. Blood 
vessels (BV) are suspended within the SAS by trabeculae. Resin 
section stained with toluidine blue. Scale bar 200  μm. Published 
with permission from Ref. [4]. b Subarachnoid space (SAS) and 
human spinal leptomeninges. Part of the spinal cord is seen bottom 
left and the thick layer of dura is at the top and to the right of the 
figure. The arachnoid has become focally detached from the overly-
ing dura. A delicate, highly perforated dorsolateral ligament (DL) 
extends from the spinal cord to the arachnoid and incorporates dor-
sal spinal nerve roots (DR). The pia has a thick underlying layer of 
subpial collagen. Scale bar 600 µm. Published with permission from 
Ref. [68]. c Human cerebral subarachnoid space looking down on to 
the pia. Branches of a histologically proven artery enter the brain. 
In the upper part of the figure the pia is reflected on to the surface 
of an artery as it enters the underlying cortex (white arrow). By this 
arrangement, the subarachnoid space is separated by a layer of pia 
from the brain and from arterioles in the brain. Towards the bottom 
of the figure, a branch of the artery is associated with a V-shaped 
depression in the pia (black arrow) as the artery enters the cortex (see 
text). Scanning electron micrograph: Scale bar 150  µm Published 
with permission from Ref. [45]
◂
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Fig. 4  Pia mater and subpial space in the adult human and mouse 
brain. a An artery in the human cortical subpial space. The pia is at 
the top and a thin layer of leptomeningeal cells derived from the pia 
(P) completely surrounds the arteriole in the subpial space. Gap junc-
tions (GJ) (see c) join adjacent pial cells. Glia limitans (G) is sepa-
rated from the artery by subpial space. Inflammatory cell (IC). Scale 
bar 6  µm. Published with permission from Ref. [109]. b A vein in 
the human cortical subpial space. The pia (P) is at the top of the pic-
ture and the thin-walled vein in the subpial space (SPS) has no coat-
ing of leptomeningeal cells. The glia limitans (G) is at the bottom of 
the picture and bundles of collagen fibres are seen within the subpial 
space (SPS). Scale bar 2  µm. Published with permission from Ref. 
[4]. c High magnification of a gap junction (GJ) between cells in the 
perivascular pia as indicated in a. Smooth muscle cell of the artery 
(SM). Scale bar 200 nm. Published with permission from Ref. [109]. 
d Surface of cerebral cortex from a normal mouse showing pia, glia 
limitans (G) and a shallow intervening subpial space containing col-
lagen fibres (Coll). A macrophage (M) adheres to the surface of the 
pia and extends a process between two pial cells (between *arrows). 
Scale bar 1 µm
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Perivascular compartments and perivascular spaces 
in the brain
Arteries and veins in the cerebral cortex
There are no perivascular (Virchow–Robin) spaces around 
arteries in the normal human cerebral cortex (Fig. 5a, b). 
As arteries enter the surface of the human and rodent brain 
parenchyma perpendicular to the surface of the cerebral 
cortex, they carry with them a single-layered sheath of pial 
cells that intervenes between the outer aspect of the artery 
and the glia limitans (Fig. 5a, b) [64, 103, 109]. Figure 5a 
shows an artery in the human cerebral cortex in which the 
perivascular compartment is composed of compacted layers 
of smooth muscle cells, basement membrane and pia closely 
associated with the basement membrane and astrocyte end 
feet of the glia limitans but there is no actual space [109]. 
A similar arrangement is seen in arteries in the mouse brain 
(Fig. 5b) [64]. Perivascular macrophages are embedded in 
the basement membranes that surround arteries and other 
blood vessels in the normal brain [37].
There has been much debate for many years regarding 
the presence of periarterial (Virchow–Robin) spaces around 
arteries in the cerebral cortex. Much of the confusion has 
arisen first from artefact in histological and electron micro-
scope preparations due to swelling of perivascular astrocytes 
thus forming an artefactual space around cortical arteries 
[81]. Second, there has been misinterpretation of anatomical 
features. For instance, the subpial space shown in Fig. 4a 
has been mistaken for an intracortical periarterial space. 
Similarly, the subarachnoid space has been mistaken for 
perivascular spaces around cortical arteries. For example, 
in descriptions of the “glymphatic” system [46], electron 
micrographs were interpreted as intracortical periarterial 
spaces but are, in reality, subarachnoid space. In their illus-
trations [46], the authors show electron micrographs which 
they claim to show periarteriolar spaces within the brain. 
There are two layers of leptomeningeal cells with an inter-
vening space in the figure; one layer of leptomeningeal cells 
is associated with the surface of an artery and the other layer 
is the pia mater associated with the glia limitans on the sur-
face of the brain. This strongly suggests that the intervening 
space is subarachnoid space as intracortical arterioles have 
only one layer of leptomeningeal cells associated with their 
walls and no periarteriolar space (Fig. 5a) [109]. Further-
more, the entry of tracers from the CSF into the brain is 
along pial–glial basement membranes as shown by electron 
microscopy (Fig. 5b) [64] and by high-resolution confocal 
microscopy (Albargothy, Hawkes and Carare submitted 
paper) and not along periarteriolar “spaces”.
Veins in the human cerebral cortex usually have only iso-
lated leptomeningeal cells associated with their walls and 
no complete coating of leptomeningeal cells [109]; small 
blebs of perivenous space are seen [109]. Within the subpial 
spaces, the leptomeningeal layer may be absent around veins 
(Fig. 4b) [4] but as veins pass into the SAS they acquire a 
complete layer of leptomeningeal cells [109].
Periarterial basement membranes as routes for bulk flow 
of fluid and solutes into and out of the brain
Studies using high-resolution confocal microscopy and elec-
tron microscopy suggest that basement membranes in the 
walls of cerebral capillaries and arteries are major pathways 
for the bulk flow of fluid and solutes into and out of the brain 
[18, 64]. Tracers injected into the cisterna magna enter the 
brain from the CSF along pial–glial basement membranes 
on the outer aspects of cerebral arteries [64] (Albargothy, 
Hawkes and Carare submitted paper) (Fig. 5a), and leave 
the brain along basement membranes within the walls of 
capillaries and arterioles (Albargothy, Hawkes and Carare 
submitted paper). Intracerebral injections of fluorescent trac-
ers suggest that interstitial fluid and solutes drain rapidly out 
of the brain along basement membranes in the walls of capil-
laries and along basement membranes surrounding smooth 
muscle cells in the tunica media of cerebral arterioles and 
arteries [7, 16–18] [the Intramural Peri-Arterial Drainage 
(IPAD) pathway]; IPAD is impaired with age in mice [40]. 
Similarly, accumulation of amyloid β (Aβ) in basement 
membranes of capillaries and arteries in human cerebral 
amyloid angiopathy (CAA) suggests that IPAD pathways are 
also impaired with age and Alzheimer’s disease (for review 
see [18]). Aβ initially accumulates in the lamina densa at 
the junction between adjacent smooth muscle cell basement 
membranes and at later stages completely separates the adja-
cent, fused basement membranes [52, 106]. The molecular 
mechanisms involved in bulk flow of fluid and solutes along 
basement membranes in the walls of cerebral capillaries and 
arteries have yet to be fully characterised.
Leptomeningeal cells surrounding arteries and veins 
in the cerebral white matter and basal ganglia
As they pass from the cerebral cortex into the subcortical 
white matter, arteries tend to be surrounded by two layers 
of leptomeningeal cells (Fig. 5c), although one layer may 
be incomplete [26]. Veins, on the other hand, usually have 
only a single layer of leptomeninges [26]. In this way arter-
ies in the white matter differ from those in the cortex and 
the arrangement of leptomeningeal coats may be related to 
the capacity of the perivascular spaces around white matter 
arteries to dilate [79, 104]. A similar arrangement of two 
coats of leptomeningeal cells is seen around arteries in the 
basal ganglia that may also exhibit dilatation of perivascular 
spaces (Fig. 5d) [75, 80].
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Fig. 5  Periarterial leptomeninges in the CNS. a An artery within the 
human cerebral cortex. There is no perivascular (Virchow–Robin) 
space around the artery as compacted layers of cells and basement 
membrane leave no space. A layer of pia (P) is closely apposed to 
the glia limitans (G) on one side and the smooth muscle (SM) coat 
of the tunica media of the artery on the other side. The lumen of the 
artery is surrounded by endothelium (End). Scale bar 1.3  µm. Pub-
lished with permission from Ref. [109]. b Distribution in the brain of 
15-nm nanoparticles injected into the CSF. Groups of 15-nm nano-
particles (Np) are seen in the pial–glial basement membrane of a cor-
tical artery 5 min after injection into the CSF of the cisterna magna in 
a mouse. Layers of the artery wall can be identified moving outwards 
from the lumen lined by endothelium (End), smooth muscle cells 
(SM). A layer of pia is separated from the glia limitans (GL) of the 
brain parenchyma by a layer of pial–glial basement membrane (BM). 
The group of nanoparticles (np) in the pial–glial basement membrane 
indicates the pathway for the entry of CSF into the brain following 
the convective influx/“glymphatic” pathway. There is artefactual 
disruption of the pial–glial basement membrane associated with the 
nanoparticles as is frequently seen related to mineral deposits [3]. 
Scale bar 500  nm. Published with permission from Ref. [64]. c An 
artery in the white matter of a 24-month-old dog brain. The lumen 
is surrounded by endothelium and smooth muscle cells (SM). There 
are two layers of leptomeninges (L1 (coloured blue) and L2 (yellow) 
surrounding the vessel wall and separating the smooth muscle coat 
of the artery from the glia limitans of the brain parenchyma. In this 
normal brain there is a narrow perivascular space between the layers 
of leptomeninges that may have the potential to expand as in human 
patients with cerebral amyloid angiopathy. Small bundles of col-
lagen fibres (Coll) are present between the layers of leptomeninges. 
The methods are described in [26]; this unpublished image is from 
the same study. Scale bar 1 μm. d Dilated perivascular space in the 
basal ganglia of a 72-year-old human brain. A scanning electron 
micrograph shows an artery lined by endothelium (E). Transmission 
electron microscopy confirmed the presence of two layers of leptome-
ninges (L1 coating the artery wall and L2) either side of the dilated 
periarterial space. The outer layer of leptomeninges is partly sepa-
rated from the basement membrane (BM) of the glia limitans. Scale 
bar 330 μm Published with permission from Ref. [75]
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Dilatation of perivascular spaces in cerebral white matter 
and basal ganglia
Although there are no perivascular spaces around arteries in 
the cerebral cortex, spaces may be present around arteries in 
the cerebral white matter [19, 79, 104], basal ganglia [75] 
and midbrain and they may become very large [80]. The 
capacity for periarterial spaces to dilate in the white matter 
and basal ganglia appears to correlate with the arrangement 
of the leptomeninges around those vessels. There is one 
layer of leptomeningeal cells around arteries in the cerebral 
cortex but there tends to be two layers of leptomeninges 
surrounding arteries in the white matter and basal ganglia 
[26, 75, 109].
Dilated perivascular spaces around arteries in the human 
cerebral white matter can be detected by MRI and by histol-
ogy and have been associated with CAA and consequent fail-
ure of drainage of interstitial fluid [19, 79, 104]. It appears 
that CAA impedes the drainage of interstitial fluid from 
cerebral white matter and results in dilatation of periarterial 
spaces, but only in the white matter and not in the grey mat-
ter of the cerebral cortex [19, 79, 104].
Dilatation of perivascular spaces in the basal ganglia is 
related to age and small vessel disease and can be detected 
by MRI [38] and by histology [75]. Two layers of leptome-
ninges surround arteries in the basal ganglia and dilated 
perivascular spaces are encompassed on each side by a 
single layer of leptomeninges as seen by scanning electron 
microscopy (Fig. 5d) and confirmed by transmission electron 
microscopy [75].
Leptomeninges as barriers and facilitators 
in the CNS
The most prominent barrier function performed by the lep-
tomeninges is the arachnoid that surrounds the outer aspect 
of the CNS; it is impermeable to CSF and thus contains the 
CSF within the SAS and separates the CSF from blood ves-
sels in the dura that have no blood–brain barrier or blood 
CSF barrier. Leptomeningeal cells also perform other barrier 
functions particularly as intervening cell layers between col-
lagen fibres and the CSF. Inflammatory cells appear to read-
ily penetrate the thin layers of leptomeningeal cells such as 
the pia but not the thicker arachnoid barrier layer. Although 
veins in the SAS are coated by a layer of leptomeningeal 
cells, the main barrier to entry of inflammatory cells from 
the blood into the CSF in the SAS is the vascular endothe-
lium lining veins in the SAS and subpial spaces [30, 31]. 
The arachnoid barrier, besides containing the CSF within 
the SAS, also plays an important role in preventing activated 
immune cells invading the CSF from dural blood vessels.
Leptomeningeal cells also facilitate the circulation of 
CSF and the attachment of inflammatory cells, tumour cells 
and the bacteria within the SAS. There is a complete lin-
ing of leptomeningeal cells around the SAS; furthermore 
leptomeningeal cells cover collagen bundles in the stroma 
of the choroid plexus, line the pathways for drainage of CSF 
into the blood through arachnoid granulations and line the 
pathways for lymphatic drainage of CSF into nasal lymphat-
ics. In addition, extensions of leptomeningeal cells into the 




In humans, the main body of the arachnoid is composed of 
closely packed leptomeningeal cells joined by desmosomes 
[4]. However, the outer barrier layer of the arachnoid that 
abuts on to the dura is composed of cells joined by tight 
junctions that prevent the escape of CSF from the SAS [4]. 
Arachnoid also acts as a barrier to the spread of inflam-
matory cells from the SAS in cases of leptomeningitis and 
resists the spread of pus from subdural infections into the 
SAS.
Leptomeningeal cells separate collagen fibres from the CSF 
in the subarachnoid space
The SAS is surrounded by connective tissue but leptomenin-
geal cells separate collagen fibres from the CSF. In this way, 
leptomeningeal cells form a smooth surface that separates 
cells circulating in the CSF from underlying tissue elements; 
this is similar to the way in which vascular endothelial cells 
form a surface for the smooth transport of blood. As dis-
cussed below, leptomeningeal cells also form a surface for 
the attachment of inflammatory cells, tumour cells and bac-
teria within the subarachnoid space. The inner layer of the 
arachnoid facing the CSF has a thin underlying layer of col-
lagen that extends into trabeculae that cross the SAS to join 
the pia or suspend subarachnoid blood vessels within the 
SAS [4, 45]. A layer of leptomeningeal cells separates the 
collagen in the arachnoid, the subarachnoid trabeculae and 
in the subpial compartment from the CSF (Fig. 6a). The lay-
ers of leptomeningeal cells performing this barrier function 
are often only one cell thick and joined by gap junctions or 
desmosomes [4, 13].
The principle of leptomeningeal cells separating collagen 
from fluid applies not only in the SAS but is also seen in 
the stroma of the choroid plexus and in cores of arachnoid 
granulations.
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Choroid plexus
Bundles of collagen are present in the stroma of the cho-
roid plexus but they are surrounded by leptomeningeal cells 
(Fig. 6b) [3]. In older humans, spheres of collagen fibres, 
produced and surrounded by leptomeningeal cells, may 
become calcified to form calcospherites in the stroma of the 
choroid plexus [3]. The anatomical arrangement suggests 
that fluid, solutes and inflammatory cells passing out of the 
blood vessels into the stroma and trafficking towards the 
choroid plexus epithelium, the site of the blood–CSF bar-
rier, are separated from collagen bundles by leptomeningeal 
cells in a similar way to the separation of collagen from CSF 
in the SAS.
Arachnoid granulations
The SAS is continuous with the core of each arachnoid gran-
ulation such that CSF flows into a network of channels in the 
core of the granulation (Fig. 6c) [56, 98]. Delicate trabeculae 
of collagen fibres form the walls of the channels but the 
trabeculae are coated by leptomeningeal cells that separate 
the collagen from the CSF within the channels. Each granu-
lation has a cap of compacted leptomeningeal cells through 
which channels pass to carry CSF to the venous endothelium 
[55, 56, 98]. CSF then appears to pass by macrovacuolar 
bulk flow through the venous endothelium into the blood 
[97]. By this arrangement, CSF is separated from collagen-
ous elements in the arachnoid granulations by a coating of 
leptomeningeal cells.
Facilitators
Layers of leptomeningeal cells lining the SAS, the stroma of 
the choroid plexus, drainage channels in arachnoid granula-
tions and the channels that drain CSF into nasal lymphat-
ics [54] facilitate the production, circulation and drainage 
of CSF. They also facilitate the movement of inflammatory 
cells within the SAS. The leptomeningeal cells of the pia 
offer little resistance to the passage of inflammatory cells 
[45, 57] (Fig. 4d) although they do block the passage of 
erythrocytes and particulate matter [45]. Similarly, the lep-
tomeningeal cells coating veins in the SAS appear to offer 
little resistance to the passage of T lymphocytes, polymor-
phonuclear leukocytes and monocytes entering the SAS 
from the blood [85, 102]. The major barrier to the passage 
of inflammatory cells from CSF into the CNS appears to be 
the glia limitans [31].
Most of the research into traffic of inflammatory cells into 
the CSF and CNS has been on experimental autoimmune 
encephalomyelitis (EAE) as an animal model of multiple 
sclerosis. Experiments in EAE suggest three potential routes 
for the entry of encephalitogenic T cells into the CNS, either 
directly from the blood or via the CSF. Migration of T cells 
from the blood into the CNS parenchyma in inflammation is 
by a two-step process [30, 31]. Step 1: T cells in the blood 
with activated α4β1-integrins (VLA4) on their surfaces 
engage VCAM-1 on endothelial cells and migrate into the 
perivascular spaces around postcapillary venules. Step 2: 
from the perivenular spaces, T cells penetrate the basement 
membrane and astrocyte processes of the glia limitans to 
enter the CNS parenchyma; this step is facilitated by the 
expression of matrix metalloproteinases (MMPs) produced 
by macrophages [30]. Encephalitogenic T cells also migrate 
across the walls of leptomeningeal veins directly into the 
CSF in the SAS [85]. Another route of entry of T cells into 
the CSF appears to be through the choroid plexus and blood 
CSF barrier into the ventricles [78].
T lymphocytes in the spinal SAS in EAE attach to the 
leptomeninges through steps reminiscent of vascular adhe-
sion in the CNS blood vessels involving integrins VLA-4 
and LFA-1 on lymphocyte cell surfaces binding to their 
respective ligands; the integrins appear to be activated 
by chemokines produced by resident macrophages [85]. 
Chemokine signalling via CCR5/CXCR3 and antigenic 
stimulation of T cells in contact with leptomeningeal mac-
rophages enforces their adhesiveness to the leptomeninges. 
T cells that become detached from leptomeninges and float 
free in the CSF display significantly lower activation levels 
compared to T cells attached to the leptomeninges and from 
the parenchyma of the CNS [85]. This suggests that attach-
ment to the leptomeninges induces more activation in the 
T cells. Invasion of T cells into CNS tissue from the CSF 
would entail crossing the glia limitans which is the main 
barrier on the surface of the CNS to the passage of inflam-
matory cells into the CNS parenchyma [30].
Arteries and leptomeningeal cells as facilitators 
for the entry of CSF into the CNS
Layers of leptomeningeal cells that accompany arteries as 
they enter the surface of the CNS appear to facilitate the 
entry of CSF into CNS tissue. When tracers are injected 
into the CSF, they enter the brain along the pial–glial base-
ment membranes on the outer aspects of cerebral arteries 
(Figs. 5b, 6a) [64]. This suggests that leptomeninges play a 
facilitating role in fluid balance between CSF and interstitial 
fluid within the CNS. Convective flow of CSF and interstitial 
fluid through the brain parenchyma driven by aquaporin 4 
as suggested by the “glymphatic” hypothesis [46] has been 
strongly contested [2, 91]. Furthermore, the suggestion that 
tracers entering the brain from the CSF are eliminated along 
perivenous pathways in the “glymphatic” system [46] has 
also been strongly disputed by Albargothy, Hawkes and 
Carare (submitted paper) who have shown that such tracers 












































































Lymphac drainage of CSF 
through the cribriform plate
Fig. 6  Leptomeninges as barriers and facilitators for the movement 
of fluid and cells. a The subarachnoid space (SAS), leptomeninges 
and the surface of the brain. Veins, arteries and lymphatics (VAL) 
in the dura are separated from the arachnoid by the arachnoid bar-
rier layer (ABL) that appears to prevent the escape of CSF from the 
SAS and the entry of solutes from the “leaky” dural blood vessels 
into the CSF. Collagen fibres (blue layers) are separated from CSF in 
the SAS by layers of arachnoid and pial cells (green). Collagen bun-
dles in the cores of trabeculae (Tb) that cross the subarachnoid space 
are also separated from CSF by leptomeningeal cells (green). Lym-
phocytes (L) and monocyte/macrophages (M) enter the SAS from the 
blood via the walls of veins and adhere to leptomeningeal cells and 
cross the pia. Similarly, tumour cells (TuC) and bacteria (Neisseria 
meningitidis (Nm), derived from the blood, adhere to leptomeningeal 
cells lining the SAS. Periarterial compartments facilitate entry of 
CSF into the brain along pial–glial basement membranes on the out-
side of the artery (green arrow). Interstitial fluid (ISF) from the brain 
drains along basement membranes in the walls of capillaries and in 
the tunica media of cerebral arteries that form the Intramural Peri-
Arterial Drainage (IPAD) pathway as indicated by the yellow arrow. 
The glia limitans (purple) forms a barrier to the entry of inflamma-
tory cells into brain tissue. b Choroid plexus. Leptomeningeal cells 
(green) cover collagen bundles and collagen whorls within the stroma 
of the choroid plexus. Fluid and solutes entering the CSF from the 
choroid plexus are derived from blood vessels (Bv) in the stroma but 
the blood CSF barrier is located in the choroid plexus epithelium. c 
Arachnoid granulation. CSF passes from the subarachnoid space 
(SAS) into channels in the core of the granulation. The channels are 
formed by trabeculae that have a core of collagen (blue) covered by 
leptomeningeal cells (green). CSF then flows into channels within 
the meningeal cap to reach the venous endothelium and pass into the 
venous sinus (VS). In this way, the CSF is separated from collagen 
bundles by leptomeningeal cells as it drains through the arachnoid 
granulation. Arachnoid: AM. d Lymphatic drainage of CSF through 
the cribriform plate. Channels lined by leptomeningeal cells (green) 
pass from the subarachnoid space (SAS) inferior to the olfactory 
bulbs, through the cribriform plate alongside olfactory nerves (ON) 
into the nasal mucosa. These channels develop during foetal life and 
form a major pathway for drainage of CSF to lymph nodes. Arach-
noid: AM
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are eliminated from the brain along basement membranes in 
the walls of capillaries and arteries—IPAD (Fig. 6a).
Leptomeningeal cells facilitate lymphatic drainage of 
CSF via the cribriform plate and nasal submucosa [54] in 
both foetal and adult human and rodent brains (Figs. 1c, 6d). 
Channels lined by leptomeningeal cells form in the suba-
rachnoid space under the olfactory bulbs and pass through 
the cribriform plate alongside olfactory nerves into the 
nasal submucosa [54]. This system for the drainage of CSF 
appears to develop before the appearance of arachnoid villi 
and granulations.
Tumour cell invasion of subarachnoid spaces 
and adherence to leptomeninges
Three major categories of tumours cause Meningeosis 
neoplastica: namely carcinomas, lymphomas and primary 
tumours of the CNS, particularly medulloblastomas [28, 77]. 
However, little is known about the mechanisms by which 
tumour cells enter the SAS or are maintained within the 
CSF.
Tumour cells frequently accumulate in regions in which 
there is reduced circulation of CSF, such as the basal cis-
terns, cauda equina and hippocampal fissures. Medulloblas-
tomas have received considerable attention as most deaths 
from this disease are due to leptomeningeal metastases [77]. 
Four major molecular subgroups of medulloblastoma have 
been recognised: wingless (WNT), sonic hedgehog (SHH), 
group 3 and group 4 [77] but whole genome landscapes 
have revealed additional new molecular subtypes [69]. It is 
predicted that molecular characterisation will lead to more 
targeted therapies for leptomeningeal metastases of medullo-
blastoma [67]. In vitro and in vivo data suggest that expres-
sion of α9 and β1 integrins, in combination with tenascin 
in the extracellular matrix, mediate the adhesion of medul-
loblastoma cells to the leptomeninges [33]. Blockade of α9 
and β1 integrin binding by antibodies reduces tumour cell 
survival which suggests that adhesion of medulloblastoma 
cells to the meninges is necessary for the survival and pro-
liferation of tumour metastases in the SAS [33].
Leptomeninges as barriers and facilitators 
of bacterial meningitis
Leptomeningitis is an acute, compartmentalised intracra-
nial inflammatory response centred on the leptomeninges 
and can be caused by a plethora of different bacteria that 
can gain access to the SAS [20]. Neisseria meningitidis 
(meningococcus) is a well-studied exemplar for understand-
ing the interactions between bacterial ligands and receptor 
molecules on blood vessel endothelium and the leptome-
ninges. In the pathogenesis of meningococcal meningitis, 
the bacteria interact with several physical cellular barriers 
including the mucosal epithelium of the nasopharynx, the 
blood compartment, endothelial cells of blood vessels that 
separate the blood from the CSF-filled SAS, and the lep-
tomeninges. Meningococci express a variety of surface 
ligands that mediate their attachment to human cells and 
enable meningococci to cross these cell barriers, by inter- 
and/or intracellular routes.
Meningococcal bacteraemia
Bacteraemia is a pre-requisite for the entry of bacteria into 
the CSF and the development of meningitis. The fact that 
meningitis commonly presents without fulminant sepsis 
also suggests that bacteraemia is asymptomatic. Menin-
gococci have evolved strategies to avoid innate immune 
defence mechanisms and they express several factors that 
are important for survival in the blood. Both the capsule 
polysaccharide (CPS) and lipooligosaccharide (LOS) exhibit 
characteristic antigenic variation and molecular mimicry 
that enable meningococci to avoid antibody deposition, com-
plement-mediated killing and phagocytosis. For example, 
the α(2-8) N-acetyl-neuraminic acid linked homopolymer 
of serogroup B CPS is structurally identical to a modifica-
tion of mammalian neural cell adhesion molecule (N-CAM) 
[95]. Sialylation of LOS enables meningococci to mimic 
host cell surfaces that express sialic acid [60] and to interact 
with myeloid cell SIGLECs (sialic acid-binding, immuno-
globulin-like lectins). Phosphoethanolamine modification 
of LOS can increase adherence to human cells and also 
protects meningococci from neutrophil extracellular trap 
(NET)-bound cathepsin G [58]. Natural release of outer 
membranes (OM) and expression of the ZnuD surface pro-
tein also enable meningococci to escape NET interactions. 
Other surface-exposed proteins important for bacterial sur-
vival include TspB (T/B cell-stimulating protein B), TbpA/
TbpB (Transferrin-binding proteins), LbpA/LbpB (Lactofer-
rin-binding proteins), HpuA/HpuB/HmbR (Haemoglobin-
binding receptors), Ig-binding protease and NHBA (Neis-
seria Heparin Binding Protein). Meningococci also avoid 
complement killing through expression of Porin A that binds 
the complement inhibitor C4 bp protein [47], and of fHbp 
(factor H binding protein), NspA (Neisserial surface protein 
A) and PorinB3, which all bind human factor H [35, 88].
Attachment and penetration of vascular endothelium
Meningococci show a tropism for microvasculature endothe-
lial cells and bacterial invasion of the SAS requires menin-
gococci to breach the blood–CSF barrier (BCSFB), located 
either at the choroid plexus or in the veins within the SAS. 
Post-mortem studies of meningococcal meningitis patients 
demonstrated the adherence of bacteria to endothelial cells 
of choroid plexus capillaries, but no bacteria were found 
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inside choroidal epithelial cells or penetrating the tight junc-
tions [76]. Furthermore, leptomeningitis is centred within 
the SAS and ventriculitis is usually a late complication, 
indicating that unchecked bacterial proliferation in the SAS 
eventually spreads to other CSF-filled compartments. Thus, 
meningococci probably do not traverse the BCSFB at the 
choroid plexus and are likely to enter the CSF via veins 
in the SAS, with the blood vessel endothelium as the first 
barrier.
Meningococcal adherence to the endothelial cell barrier 
and the mechanism of traversal has been extensively studied 
[24]. The Type 4 pilus (Tfp) adhesin promotes the initial 
binding event between meningococci and endothelial cells, 
but only in microvessels where blood flow shear stresses 
are low. Expression of the Tfp-associated protein PilX 
stimulates bacterial aggregation and spreading across the 
cell surface [41]. Adherence occurs through the interaction 
between Tfp and the CD147 (extracellular matrix (ECM) 
MMP inducer, EMMPRIN or Basigin)–β2-adrenergic recep-
tor (β2AR) complex, with the Tfp subunit PilE protein and 
associated PilV protein interacting directly with the extra-
cellular N-terminal domain of the β2-adrenergic receptor. 
Activation initiates a signalling pathway that leads to the 
formation of ‘cortical plaques’ of cytoplasmic ezrin and 
ezrin-binding and actin microfilament-binding proteins. Sig-
nalling leads to relocation of vascular endothelial cadherin 
from endothelial cell junctions at the sites of bacterial adher-
ence, and also induces the production of MMP8 that pro-
motes cleavage of the tight junction protein occludin [87]. 
Other Tfp-associated proteins that may be involved in cell 
interactions include the tip-associated PilC1/C2 and a phos-
phorylcholine modification of Tfp that interacts with Platelet 
Activating Factor receptor [48]. Adherence of meningococ-
cal also stimulates endothelial cells to release cytokines, 
chemokines and reactive oxygen and nitrogen species [21], 
that contribute to cell stress and degradation of intercellular 
junctions. Thus, crossing the endothelial barrier is primarily 
by the intercellular route. An intracellular route of invasion 
is possible, though considered to be secondary: retraction of 
Tfp draws meningococci towards the endothelial cell plas-
malemma and concomitant down-regulation of CPS expres-
sion exposes OM adhesins and invasins that can interact 
with endothelial cell receptors to promote internalisation of 
bacteria. These include the well-characterised Opa (colony 
opacity-associated), Opc (5C), NadA (Neisserial adhesin A) 
proteins and the OmpA-like sequence of RmpM (Reduction 
modifiable protein M) (Table 2).
Penetration of leptomeningeal layers
After crossing the vessel endothelium, meningococci will 
encounter a thin layer of connective tissue and then the 
leptomeningeal coating that encloses the vein within the 
CSF-filled SAS. The mechanism by which meningococci 
penetrate this leptomeningeal coating is unclear, but the fact 
that meningeal cells do not internalise meningococci sug-
gests intercellular penetration, perhaps as a consequence of 
degradation of desmosomes and other junctions by endothe-
lial cell metabolites. It is possible that the ErbB family 
receptor protein EGFR on leptomeningeal cells (Table 2) is 
activated by meningococcal infection. In endothelial cells, 
EGFR, Erb2 and Erb4 are activated in response to meningo-
coccal infection and involved in the internalisation of bacte-
ria [90]. However, activation of EGFR on the leptomeninges 
could be involved in weakening intercellular junctions to 
allow transmigration of meningococci, mimicking a pro-
cess that has been described for transmigration of N. gonor-
rhoeae across polarised epithelial cells [29].
The ability of meningococci to weaken endothelial and 
leptomeningeal intercellular junctions is a trafficking mecha-
nism shared with T lymphocytes, B cells, PMNL and other 
myeloid cells for their entry into the CNS, and includes acti-
vation of MMP proteins [30]. However, the nature of the 
ligands used by trafficking immune cells and their targeted 
receptors appear to be distinct from those used by meningo-
cocci. Interestingly, Tfp-mediated adherence of Neisseriae 
to the uropod of polarised PMNL suggests a hypothesis that 
the bacteria can hitchhike on PMNL both to hide from their 
phagocytic activity and to enable dissemination through cell 
barriers [92].
Adherence of meningococci to leptomeningeal cells
The CPS and Tfp phenotype of N. meningitidis, which is 
normally isolated from blood and the CSF, shows a spe-
cific predilection for binding to leptomeninges but not to 
cortical brain tissue (Fig. 7a, b) [39]. Meningococci adhere 
similarly to the surface of cultured tumour cells derived 
from benign meningiomas arising from the leptomeninges 
(Fig. 7c). Meningioma cells share many structural features 
with normal leptomeningeal cells [32]; they are character-
ised by the presence of desmosomes, and, except in certain 
sites in the leptomeninges, tight junctions are absent. Both 
types of cell express the cytoplasmic intermediate filament 
proteins nestin Type VI, cytokeratin and vimentin Type II 
and the microtubule-associated protein doublecortin and 
both secrete Type IV collagen, Type III procollagen, tenas-
cin and fibronectin ECM proteins. Meningioma cells provide 
an in vitro model for studying meningitis and all the major 
meningeal pathogens can adhere to these cells (Fig. 7c) [5, 
9, 34, 39], although the nature of the bacterial ligands and 
meningeal cell receptors has not been explored extensively.
The type 4 pilus (Tfp) is the primary ligand that mediates 
adherence of meningococci to leptomeningeal cells [39], and 
Tfp-mediated adherence is not influenced by CPS expres-
sion, the antigenic class of pilus expressed (Class I or Class 
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Table 2  Profile of known and potential surface receptor molecules on human leptomeningeal cells and meningioma cells
Molecule Receptor function and meningococcal ligand recognised
Laminin receptor 1 (LamR; also known as RPSA)–galectin 3 (GAL3) 
complex)
Binds PorA and PilQ [73] and NhhA (Neisseria hia/hsf homologue; 
Msf, meningococcal surface fibril) [84]
Heparan sulphate proteoglycans (HSPG) Binds NhhA [84], NHBA (Neisseria Heparin Binding Antigen) [99], 
Opa and Opc proteins [42]
Integrins (α1, α2, α3, α4, α5, α6, β1, β4) Expressed to varying degrees in meningioma/meningeal cells. Bind Opa 
proteins (which also recognise CEACAM (carcinoembryonic antigen-
related cell adhesion molecule) family receptor proteins) and Opc 
protein [42]. β1-integrin binds NadA (Neisserial adhesin A (autotrans-
porter TAA adhesin–invasin) [66]
MARCO (Class A Mo scavenger receptor (SR-A) and macrophage 
receptor with a collagenous structure)
Expressed on (rodent) meningeal cells. Binds to various meningococ-
cal proteins (NMB0278, DsbA; NMB0346, NMB0667, NMB1513, 
hypothetical; NMB1220, Stomatin/Mec-2 family protein; NMB1567, 
Macrophage infectivity potentiator) [74]
CD46 (membrane co-factor protein) Expressed on all cell types except erythrocytes. Putative receptor for 
Tfp [51]
TLR2 Toll-like receptor 2: pathogen recognition receptor (PRR) for Gram-
positive lipoteichoic acid and other lipoproteins and meningococcal 
PorB [96]
TLR4 Toll-like receptor 4: PRR for LOS endotoxin
Epidermal growth factor receptor (EGFR) Transmembrane protein with intrinsic tyrosine kinase. Microbial ligand-
binding to EGFR potentially activates cell signalling, phosphorylates 
protein kinases, and rearranges cytoskeletal proteins, thus facilitating 
pathogen uptake
HLA-DR Do phagocytic arachnoid cells act as antigen-presenting cells?
Interleukin-1R Binds Interleukin 1 cytokine
N-CAM Surface glycoprotein CD56; mimicked by serogroup B CPS
Fcγ receptors Potential phagocytosis-related functions; increased by GM-CSF produc-
tion
Bone morphogenetic protein (BMP) 4 and 7 receptors Expressed on leptomeninges—BMPs influence vascular development in 
this tissue
CD44 Multi-structural glycoprotein with functions in cell proliferation, dif-
ferentiation, migration, angiogenesis, signalling pathways for cell 
survival, presentation of innate molecules and proteases to receptors
Desmosomal desmoplakin Protein component of desmosomes, which are meningeal cell intercel-
lular junctions. Desmosomes function in cell–cell adhesion and for the 
attachment of intermediate filaments (IF)
G protein-coupled melatonin receptor Mel1a Receptor for melatonin that may play role in early neural development
YKL-40 Heparin- and chitin-binding glycoprotein, participates in inflammatory 
states
β-Type platelet-derived growth factor (PDGF) receptor PDGF stimulates tumourigenesis in arachnoid cells
CXCR4 and CXCR7 chemokine receptors Involved in tumour cell proliferation and survival
Endothelin receptors Role in tumour growth
Epithelial membrane antigen Marker of meningioma; also known as mucin glycoprotein CD227, 
MUC1, episialin. Normally acts as a barrier to apical cell surfaces
Fibroblast growth factor receptor-1 (FGFR-1) Associated with meningioma cell growth and tumourigenesis
Mesothelin Function unknown, possibly a tumour marker
Prolactin receptor (PRLR) Detected in meningiomas; proliferative effects
Sex hormone receptors (progesterone, oestrogen, androgen, aromatase) May play a role in the tumorigenesis of meningiomas
Somatostatin receptor (hsst) 2a Binds somatostatin hormone; diagnostic marker for meningioma
TGF-β receptors Receptor loss related to malignancy
Histones Intracellular proteins that can associate with App (Adhesion and 
penetration autotransporter protein) and MspA/Aus1 (meningococcal 
serine protease A/autotransporter serine protease 1) [53]
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II) or by variable expression of PilC1 protein. However, vari-
ation within Class I pilin that modifies pilin structure and/or 
the ability to form bundled pili, does influence meningococ-
cal adherence to leptomeningeal cells, as similarly observed 
with epithelial and endothelial cells. For capsulated bacte-
ria, expression of Opc protein is not involved in mediating 
adherence, whereas expression of Opa protein does increase 
the association of capsulated meningococci that express 
low-adhesive pili, but do not influence the association of 
high-adhesive piliated bacteria [39]. Expression of TspA (T 
cell-stimulating protein A) has been reported to contribute 
to the adhesion of meningococci to meningioma cells [72]. 
Only one other protein, the Adhesin Complex Protein, has 
been reported to bind directly to cell surfaces and mediate 
adherence of capsulated meningococci to meningeal cells 
[44]. A comprehensive classification of the leptomeningeal 
surface receptors directly binding meningococcal ligands is 
lacking, but can be generated hypothetically from what is 
known currently of bacterial ligand interactions with other 
cell types and the nature of receptors identified on leptome-
ninges and meningioma cells (Table 2).
The OM of CPS-null meningococci has been shown to 
interact intimately with the meningioma cell plasmalemma, 
inducing significant cell surface activation and membrane 
ruffling, that are not observed following the binding of cap-
sulated meningococci [39]. It is likely that exposed OM 
adhesin–invasins such as the Opa and Opc proteins medi-
ate these interactions, which occur also on endothelial and 
epithelial cells. However, the meningeal cell receptors 
involved have not been confirmed. Despite these membrane 
rearrangements, meningococci do not invade meningioma 
cells and classical membrane-bound intracellular vacuoles 
containing bacteria are not observed [39]. Since bacteria 
and the inflammatory response are contained within the 
SAS, with little involvement of the underlying brain, this 
suggests that an intact pia is a considerable barrier to pen-
etration of meningococci into the brain. Nonetheless, late-
stage and fatal meningitis is characterised by considerable 
death of leptomeningeal cells, thus presenting bacteria with 
the opportunity to interact with collagen underlying the pia 
and with astrocytes of the glia limitans superficialis and to 
potentially activate microglia.
Leptomeningitis
After entry into the CSF, leptomeningitis is established as a 
consequence of bacterial growth without immune restriction 
in the SAS and the direct interactions of meningococci with 
microvascular endothelial cells, the leptomeninges (with 
little involvement of the dura) and sentinel macrophages. 
LOS is the major component of meningococci that induces 
leptomeningitis [12], via binding to CD14-Toll-like receptor 
Fig. 7  Interactions of pathogenic Neisseria meningitidis with human 
leptomeninges. a Control cryostat section of human brain stained by 
immunocytochemistry for vimentin. Arachnoid (Ar) with underlying 
sulcus and subarachnoid space (SAS) containing CSF that separates 
cerebral cortex on either side. Blood vessel (BV) in the sulcus. b The 
same section as in a infected with N. meningitidis (green) that adhere 
to the leptomeningeal cells in the arachnoid, coating trabeculae and in 
the pia and coating blood vessel wall within the subarachnoid space 
(SAS) of the sulcus. Cortex is labelled on one side of the sulcus and 
pia is indicated by an arrow on the other side of the sulcus. N. men-
ingitidis do not adhere to the cortical brain tissue. c Adherence of 
N. meningitidis (yellow–green) to meningothelial meningioma cells 
(red) in culture. a, b Fluorescence microscopy scale bar 300  μm. c 
Confocal microscopy: scale bar 20 μm a–c Published with permission 
from Ref. [39]
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(TLR)4-MD2 on endothelial cells, macrophages and infil-
trating PMNLs. Such interactions activate cell signalling 
pathways to induce the inflammatory response. By contrast, 
cytokine release by meningeal cells can occur independently 
of LOS-CD14/TLR4/MD2 interactions or the involvement 
of other host accessory proteins such as HSP70, HSP90α, 
CXCR4 or GDF5 [43]. Leptomeningitis is an ‘inflammatory 
soup’ of host response molecules [21] to invading menin-
gococci and infection is characterised by the rapid infiltra-
tion of PMNLs. Neutrophils with intracellular bacteria have 
been observed in the CSF of patients, suggesting that this 
organism can survive and replicate within these cells [25]. 
Infiltrating PMNL augment the inflammatory response, and 
leptomeningitis serves to limit bacterial spread but at the 
expense of the host, leading to gross cell and tissue necrosis 
within the SAS. Untreated meningococcal leptomeningitis 
is invariably fatal and for survivors, permanent neurological 
sequelae are common.
Conclusions
This review has emphasised the key roles that leptomenin-
geal cells, in their many and diverse forms, play as barriers 
and facilitators for the movement of fluid, solutes, cells and 
bacteria in relation to the CNS. In foetal development the 
establishment of the arachnoid barrier complements the for-
mation of the blood–brain barrier thus isolating the CSF and 
developing CNS from peripheral tissues that lack vascular 
barriers. Such isolation appears to be essential for ensuring 
appropriate morphogenic signalling within the CNS which 
is concentration-dependent and in which the arachnoid may 
play a part. The arachnoid barrier is retained in the adult 
brain and is prominent in containing CSF within the suba-
rachnoid space and isolating the CSF from the dura. Lep-
tomeninges also play many other subtle roles as summarised 
in Fig. 6, ranging from separation of connective tissue from 
the CSF to lining channels for the movement of CSF within 
the brain and drainage of CSF via arachnoid granulations 
and lymphatic pathways. Within the cranial and spinal SAS, 
leptomeninges appear to regulate patterns of flow for CSF 
and are sites for attachment of inflammatory cells which 
may facilitate their immunological and anti-microbial activi-
ties. Bacteria and tumour cells enter the CSF and attach to 
leptomeninges by mechanisms that may involve molecular 
mimicry and hijacking some of the attachment mechanisms 
used by inflammatory cells. Understanding such mecha-
nisms has a potential role for the future management of lep-
tomeningitis, autoimmune disorders of the CNS and tumour 
metastases in the CSF.
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